Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending October 21, 2022

Drug Industry TRx: +0.7% w/w; +7.3% y/y

Vascepa
TRx 63,203; +1.1% (+688) w/w; -21.9% y/y
NRx 28,976; +3.3% (+924) w/w; -20.5% y/y
Ref 34,227; -0.7% (-236) w/w; -22.9% y/y

Fake Vascepa
TRx 41,918; +5.1% (+2,024) w/w; As % of total V: 39.9%
NRx 20,195; +6.7% (+1,259) w/w; As % of total V: 41.1%
Ref 21,723; +3.6% (+765) w/w; As % of total V: 38.8%

Fake Vascepa by Manufacturer
Hikma - TRx 14,391; -223 w/w; Generic share 34.3%; Total V share 13.7%
Reddy - TRx 19,723; +2,010 w/w; Generic share 47.1%; Total V share 18.8%
Apotex - TRx 7,604; +225 w/w; Generic share 18.1%; Total V share 7.2%
Teva - TRx 201; +12 w/w; Generic share 0.5%; Total V share 0.2%

Vascepa + Fake Vascepa
TRx 105,122; +2.6% (+2,712) w/w; +3.6% y/y
NRx 49,172; +4.6% (+2,183) w/w; +1.8% y/y
Ref 55,950; +1.0% (+529) w/w; +5.1% y/y

Lovaza (Fake & Brand)
TRx 64,762; +4.0% (+2,513) w/w; +3.2% y/y
NRx 31,443; +3.9% (+1,171) w/w; +2.3% y/y
Ref 33,319; +4.2% (+1,342) w/w; +4.0% y/y